Icon

VYLEESI (AUTOINJECTOR) (nda210557)- (EQ 1.75MG BASE/0.3ML (EQ 1.75MG BASE/0.3 ML))

BREMELANOTIDE ACETATE COSETTE
EQ 1.75MG BASE/0.3ML (EQ 1.75MG BASE/0.3 ML)
No No
2041-Apr-29 2024-Jun-21
None None
None No
VYLEESI is a melanocortin receptor agonist indicated for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD) as characterized by low sexual desire that causes marked distress or interpersonal difficulty and is NOT due to: • A co-existing medical or psychiatric condition, • Problems with the relationship, or • The effects of a medication or drug substance.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 1.75MG BASE/0.3ML (EQ 1.75MG BASE/0.3 ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.